Literature DB >> 10717387

Loss of the Fanconi anemia group C protein activity results in an inability to activate caspase-3 after ionizing radiation.

C Guillouf1, J P Vit, F Rosselli.   

Abstract

Fanconi anemia (FA) is a human genetic disease featuring cancer predisposition, genetic instability and DNA damage hypersensitivity. Although abnormalities in DNA repair and cell cycle checkpoint have been proposed as the underlying defect in this syndrome, these hypotheses did not provide full explanations of the complex phenotype. Although not exclusive of such possibilities, alterations in the control of apoptosis might account for the pleiotropic phenotype of this syndrome. We and others have previously reported a deregulation of the apoptotic response to mitomycin C, suggesting that the products of the Fanconi anemia group C protein (FANCC) contribute to the regulation of apoptosis. To explore the functional importance of the apoptotic alterations in FA we analyzed biochemical steps of the execution phase of apoptosis stimulated by another DNA damaging agent, the gamma-ray using FA cell lines derived from complementation group C (FA-C) independent patients. It is shown that the poly(ADP-ribose) polymerase, a target of caspase-3, is not cleaved in FA-C after ionizing radiation (IR). Moreover, caspase-3 is not processed in its active form and, its activity is not increased by IR in FA-C cells compared to normal cells. Altogether, these results demonstrate that loss of the FANCC activity results in a deficiency of the IR-induced apoptosis which is due to an inability to activate caspase-3. Our work suggests that apoptosis signaling induced by mitomycin C and IR is subject to common regulation involving the FANCC protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10717387     DOI: 10.1016/s0300-9084(00)00359-x

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  6 in total

1.  Use of DNA-damaging agents and RNA pooling to assess expression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients.

Authors:  Logan C Walker; Bryony A Thompson; Nic Waddell; Sean M Grimmond; Amanda B Spurdle
Journal:  PLoS Genet       Date:  2010-02-19       Impact factor: 5.917

Review 2.  TNF-α signaling in Fanconi anemia.

Authors:  Wei Du; Ozlem Erden; Qishen Pang
Journal:  Blood Cells Mol Dis       Date:  2013-07-24       Impact factor: 3.039

3.  The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways.

Authors:  Pietro Pichierri; Filippo Rosselli
Journal:  EMBO J       Date:  2004-02-26       Impact factor: 11.598

4.  Electrochemically Reduced Water Delays Mammary Tumors Growth in Mice and Inhibits Breast Cancer Cells Survival In Vitro.

Authors:  Giovanni Vanni Frajese; Monica Benvenuto; Rosanna Mattera; Saverio Giampaoli; Elena Ambrosin; Roberta Bernardini; Maria Gabriella Giganti; Loredana Albonici; Ivan Dus; Vittorio Manzari; Andrea Modesti; Maurizio Mattei; Roberto Bei
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-26       Impact factor: 2.629

5.  PARP1 activation/expression modulates regional-specific neuronal and glial responses to seizure in a hemodynamic-independent manner.

Authors:  J-E Kim; Y-J Kim; J Y Kim; T-C Kang
Journal:  Cell Death Dis       Date:  2014-08-07       Impact factor: 8.469

6.  P2X7 receptor-mediated PARP1 activity regulates astroglial death in the rat hippocampus following status epilepticus.

Authors:  Ji Yang Kim; Ah-Reum Ko; Ji-Eun Kim
Journal:  Front Cell Neurosci       Date:  2015-09-04       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.